These observations, collectively, prompt us to hypothesise that the high frequency of cytoplasmic Survivin in primary GBM may increase the barriers to cell apoptosis, accelerate the oncogenic process of primary GBM, in particular, facilitate the development of primary GBM in a short period without an identifiable less-malignant pre-existing lesion. The gene discussed is BIRC5; the disease is glioblastoma.